Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, discusses the genetic risk (or lack thereof) for lung cancer.
Video Library
Search the Video Library
Video Language
Filter by Cancer Type:
Displaying Results 1 - 15 of 20
For our Mandarin-speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library. In this video translation, Dr. Li discusses consolidation radiation after a good response to first-line therapy. We would
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library. In this video translation, Dr. Li discusses evolving standards for molecular testing in advanced NSCLC. We would like to
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library. In this video translation, Dr. Li discusses the current status of Tumor Mutation Burden (TMB). We would like to thank the
Dr. Sandip Patel, Associate Professor of Medicine at the Moores Cancer Center, UC San Diego Health, joined GRACE to offer updates to our Lung Cancer Video Library. In this video, Dr. Patel discusses the current status of tumor mutation burden. We thank the following organizations for their support
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, defines oligometastatic lung cancer and describes the recent trend toward the use of stereotactic body radiation therapy to treat it.
Dr. Nathan Pennell, Cleveland Clinic, describes treatment of NSCLC patients with HER2 mutations using agents such as Gilotrif or Herceptin.
Dr. H. Jack West, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, President and CEO of GRACE offers updates to our Lung Cancer Video Library. In this video, Dr. West discusses chemotherapy and immunotherapy combinations in advanced squamous non-small cell lung cancer. We thank
Dr. Jenni Li joins GRACE as guest faculty to provide updated information to our Mandarin Lung Cancer Video Library, for our mandarin speaking community. In this video, Dr. Li shares information on the leading treatment options for patients with advanced NSCLC and high tumor PD-L1 expression. To join
Dr. Jenni Li joins GRACE as guest faculty to provide updated information to our Mandarin Lung Cancer Video Library, for our mandarin speaking community. In this video, Dr. Li shares information on the leading treatment options for patients with low or negative tumor PD-L1 expression and advanced non
For this addition to the Lung Cancer Video Library, Dr. Millie Das joins GRACE to discuss current updates in treatment options for non small cell lung cancer. In this video, Dr. Das discusses the current leading treatment options for patients with low or negative tumor PDL1 expression and advanced
Dr. Jenni Li joins GRACE as guest faculty to provide updated information to our Mandarin Lung Cancer Video Library, for our mandarin speaking community. In this video, Dr. Li discusses the leading treatment options for patients with low or negative tumor PD-L1 expression and advanced squamous NSCLC
Dr. Mojun Zhu joins GRACE as guest faculty to provide updated information to our Mandarin Lung Cancer Video Library, for our mandarin speaking community. In this video, Dr. Zhu discusses if immunotherapy can help frail patients with advanced NSCLC. ***** Zhu Mojun Zhu博士加入GRACE任客座教授,为普通话社区提供最新信息
For this new addition to the GRACE Lung Cancer Video Library, Dr. Josh Bauml joins GRACE to discuss current updates in treatments for non small cell lung cancer. In this video, Dr. Bauml discusses updated information on emerging molecular targets in nsclc - RET fusions. To join the conversation
For this new addition to the GRACE Lung Cancer Video Library, Dr. Josh Bauml joins GRACE to discuss current updates in non small cell lung cancer. In this video, Dr. Bauml discusses updated information on emerging molecular targets in nsclc - MET. To join the conversation, visit https://cancergrace